Your browser doesn't support javascript.
loading
Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone.
Bianchini, D; Lorente, D; Rodriguez-Vida, A; Omlin, A; Pezaro, C; Ferraldeschi, R; Zivi, A; Attard, G; Chowdhury, S; de Bono, J S.
Afiliação
  • Bianchini D; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK.
  • Lorente D; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK.
  • Rodriguez-Vida A; Guy's and St. Thomas' NHS Foundation Trust, Great Maze Pond, London, UK.
  • Omlin A; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK.
  • Pezaro C; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK.
  • Ferraldeschi R; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK.
  • Zivi A; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK.
  • Attard G; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK.
  • Chowdhury S; Guy's and St. Thomas' NHS Foundation Trust, Great Maze Pond, London, UK.
  • de Bono JS; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. Electronic address: johann.de-bono@icr.ac.uk.
Eur J Cancer ; 50(1): 78-84, 2014 Jan.
Article em En | MEDLINE | ID: mdl-24074764
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Taxoides / Neoplasias de Próstata Resistentes à Castração / Androstenóis Tipo de estudo: Observational_studies Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Taxoides / Neoplasias de Próstata Resistentes à Castração / Androstenóis Tipo de estudo: Observational_studies Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Reino Unido